Current Status of Next-Generation Sequencing-Based Cancer Genome Profiling Tests in Japan and Prospects for Liquid Biopsy.

Yoshii, Yumi; Okazaki, Shunsuke; Takeda, Masayuki

Yoshii, Yumi; Okazaki, Shunsuke; Takeda, Masayuki.

Afiliação

Yoshii Y; Department of Cancer Genomics and Medical Oncology, Nara Medical University, Kashihara 634-8521, Japan.
Okazaki S; Department of Cancer Genomics and Medical Oncology, Nara Medical University, Kashihara 634-8521, Japan.
Takeda M; Department of Cancer Genomics and Medical Oncology, Nara Medical University, Kashihara 634-8521, Japan.

Life (Basel) ; 11(8)2021 Aug 06.

Article em En | MEDLINE | ID: mdl-34440540

Palavras-chave

clinical sequencing; liquid biopsy; next-generation sequencing; precision medicine; solid cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Life (Basel) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google